Home › Cardinal Health to manufacture Bayer cancer drug in new Indiana facility
 

Keywords :   


Cardinal Health to manufacture Bayer cancer drug in new Indiana facility

2014-12-23 08:47:36| Chemicals - Topix.net

Bayer HealthCare and Cardinal Health have signed a 15-year agreement for the contract manufacturing of the castration-resistant prostate cancer drug Xofigo . Under the agreement, Cardinal Health will build a state-of-the art, 64,000 square foot facility in Indianapolis, which will be dedicated exclusively to the manufacturing of Xofigo.

Tags: health drug cancer facility

Category:Chemicals

Latest from this category

All news
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
17.05Dutch Boy Paints Introduces Professional Series at Menards
17.05RadTech 2024 Sustainability Award Winners are Selected
17.05BYK-Gardner USA Launches New Dispermat Dissolver CV3evo
17.05BASF Ranks 22 on Fair360 list of Top 50 Companies for Diversity
17.05Nisar Amin Named Regional Sales Manager at JNS-SmithChem
17.05PNWSCT Coatings Fest 2024 Issues Call for Papers
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
Chemicals »
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »